Immediate Impact
3 standout
Citing Papers
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
2023 Standout
Glioma targeted therapy: insight into future of molecular approaches
2022 Standout
Works of Bethany Hanusch being referenced
Abstract LB-302: Potential role of larotrectinib (LOXO-101), a selective pan-TRK inhibitor, in NTRK fusion-positive recurrent glioblastoma
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bethany Hanusch | 6 | 4 | 2 | 3 | 9 | ||
| Shani Caspi | 5 | 4 | 3 | 4 | 9 | ||
| Simone Morando | 8 | 3 | 3 | 8 | |||
| Pietro Pugliese | 6 | 1 | 6 | 1 | 2 | 10 | |
| Elina Tsyvkin | 5 | 3 | 2 | 1 | 3 | 9 | |
| Ayse B. Ercan | 3 | 3 | 5 | 1 | 3 | 9 | |
| M-P Winter | 5 | 3 | 3 | 10 | |||
| Απόστολος Στρατόπουλος | 6 | 6 | 1 | 2 | 8 | ||
| Laurence Bouillet | 5 | 2 | 2 | 3 | 8 | ||
| Isaac Bakerman | 3 | 6 | 3 | 10 | |||
| Jeroen Koets | 4 | 2 | 2 | 2 | 10 |
All Works
Loading papers...